Sort
146,196 grants matching “diabetes”
Sporadic Alzheimer's Disease modeled with diabetes and high cholesterol in rabbit
$761,827William L Klein · Northwestern University · R56 · FY2018 · AG
Genotype First: Actionable Genetic Risk through Genotype-to-Phenotype Prediction
$761,822Ali Torkamani · Scripps Research Institute, The · R01 · FY2021 · HG
New approach for immune modulation against T1D
$761,809Weston Daniel · Evoq Therapeutics, Inc. · R44 · FY2023 · DK
Sphingolipid Biology of Inflammation and Immunity
$761,760Richard Proia · National Institute Of Diabetes And Digestive And Kidney Diseases · ZIA · FY2018 · DK
Sphingolipid Biology and Regulation of Metabolism
$761,760Richard Proia · National Institute Of Diabetes And Digestive And Kidney Diseases · ZIA · FY2018 · DK
The ARIC-PET Amyloid Imaging Study
$761,685Rebecca F Gottesman · Johns Hopkins University · R01 · FY2016 · AG
Role of Adiposomes in Diabetes-Associated Endothelial Dysfunction and Restorative Effects of Exercise and Metabolic Surgery
$761,655Abeer M Mohamed · University Of Illinois At Chicago · R01 · FY2022 · HL
Reducing Weight and Diabetes Risk in an Underserved Population
$761,631Carla A. Green · Kaiser Foundation Research Institute · R18 · FY2009 · DK
Clinical and Biochemical Features of Metabolic Dysregulation in Formerly Preterm Children
$761,618Eric Douglas Austin · Vanderbilt University Medical Center · R01 · FY2024 · HL
Obesity and Diabetes Familial Risk in Hispanic Children
$761,602Nancy F Butte · Baylor College Of Medicine · R01 · FY2009 · DK
Chemical interrogation of metabolic tissue crosstalk
$761,577Jonathan Z Long · Stanford University · DP1 · FY2024 · DK
Use of Dose Safety Controller (DSC) Artificial Pancreas in Subjects with Hypoglycemia Unawareness
$761,569Richard Scott Mauseth · Dose Safety Company · R44 · FY2014 · DK
Antimicrobial, Angiogenic Skin Substitutes for Diabetic*
$761,545John M Centanni · Stratatech Corporation · R44 · FY2006 · DK
The influence of familial social context on risk dissemination and coping
$761,502Laura M Koehly · National Human Genome Research Institute · ZIA · FY2012 · HG
Peripheral and brain levels of advanced glycation end products AGEs and incident Alzheimers disease and neuropathology
$761,451Michal Schnaider Beeri · Icahn School Of Medicine At Mount Sinai · R01 · FY2017 · AG
Transgenerational epigenetic inheritance of longevity
$761,450Anne Brunet · Stanford University · DP1 · FY2015 · AG
Effects of a Novel, Scalable, and Sustainable Patient Portal Intervention on Diabetes-Related Outcomes: A Pragmatic Randomized Controlled Trial
$761,289William Martinez · Vanderbilt University Medical Center · R01 · FY2022 · DK
Measuring Early Pregnancy Glycemia and Its Impact on Adverse Outcomes
$761,288Camille Elise Powe · Massachusetts General Hospital · U01 · FY2019 · DK
Telephone Delivered Acceptance & Commitment Therapy for Weight Loss
$761,274Jonathan B Bricker · Fred Hutchinson Cancer Center · R01 · FY2022 · DK
Abnormalities in androgens and ovarian markers in reproductive-age racially and ethnically diverse women in a prospective longitudinal cohort
$761,272Catherine Kim · University Of Michigan At Ann Arbor · R56 · FY2023 · HL
Telephone Delivered Acceptance & Commitment Therapy for Weight Loss
$761,260Jonathan B Bricker · Fred Hutchinson Cancer Center · R01 · FY2023 · DK
Risk Factors for Cognitive Decline in African-Americans
$761,232Lisa L Barnes · Rush University Medical Center · R01 · FY2012 · AG
The Integrated Stress Response in Human Islets During Early T1D
$761,167Raghavendra G Mirmira · University Of Chicago · U01 · FY2023 · DK
Genetics and Triglycerides: opportunities for new approaches to identify therapies
$761,139Qiping Feng · Vanderbilt University Medical Center · R01 · FY2024 · HL
One-compound, one-islet: A high-throughput platform for small-molecule discovery
$761,100Bridget K Wagner · Broad Institute, Inc. · U01 · FY2021 · DK